FABP4 and Insulin resistance: The results showed that DCI played a pivotal role in the hepatocellular insulin resistance of PA through the IRS-2-PI3K/AKT pathway and that PTP1B, XBP1S, SREBP-1c, FABP4, G6Pase, Pepck and other genes were potential sites in dietary supplements.